Comparative analysis of serum proteomes: Identification of proteins associated with sciatica due to lumbar intervertebral disc herniation

Xie,Peigen; Liu,Bin; Chen,Ruiqiang; Yang,Bu; Dong,Jianwen; Rong,Limin

doi:10.3892/br.2014.295

Comparative analysis of serum proteomes: Identification of proteins associated with sciatica due to lumbar intervertebral disc herniation

Authors:
- Peigen Xie
- Bin Liu
- Ruiqiang Chen
- Bu Yang
- Jianwen Dong
- Limin Rong
View Affiliations

Affiliations: Department of Spine Surgery, The Third Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510630, P.R. China
Published online on: June 16, 2014 https://doi.org/10.3892/br.2014.295
Pages: 693-698

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lumbar intervertebral disc herniation (LDH) is one of the most common orthopedic conditions that can cause lower back pain and sciatica. However, the pathogenesis of LDH is poorly understood. The aim of the present study was to use proteomic analysis of blood samples to establish whether there are serum proteins associated with LDH, which may be useful in elucidating LDH pathogenesis. The ultimate aim was to develop a simple technique for the diagnosis of LDH based on the blood samples of patients with sciatica. The study used comparative analysis of serum proteomes associated with sciatica due to LDH. A total of 30 LDH patients with sciatica, receiving treatment between August and December 2007, were selected as the experimental group (or LDH group). A total of 2 ml of blood was obtained from each of the 30 patients in the LDH group and from 30 healthy volunteers, who constituted the control group. Two‑dimensional electrophoresis of the blood samples was conducted, distinct protein spots were identified by matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry and proteins associated with LDH were detected. An enzyme‑linked immunosorbent assay (ELISA) was developed to screen for the LDH proteins and was tested on the sera of a second test and control group that included 10 patients with LDH and 10 healthy subjects, respectively. Based on signal intensity, the expression levels of 6 proteins on the dielectrophoretogram were found to be significantly associated with LDH. The identities of the LDH proteins were upregulated apolipoprotein‑L1 (APO‑L1) and two types of serum albumin precursors, and downregulated apolipoprotein M (APO‑M), tetranectin (TN) and immunoglobulin light chain (IGL). Further ELISA experiments confirmed that there were increased serum levels of 4 out of the 6 proteins in patients with sciatica due to LDH, which was statistically different compared to the healthy subjects. In conclusion, these results suggest that serum APO‑L1, TN, APO‑M and IGL may serve as LDH biomarkers.

View Figures

View References

1	Macfarlane GJ, Thomas E, Croft PR, et al: Predictors of early improvement in low back pain amongst consulters to general practice: the influence of pre-morbid and episode-related factors. Pain. 80:113–119. 1999. View Article : Google Scholar : PubMed/NCBI
2	Frymoyer JW: Lumbar disc disease: epidemiology. Instr Course Lect. 41:217–223. 1992.
3	Long DM: Decision making in lumbar disc disease. Clin Neurosurg. 39:36–51. 1992.PubMed/NCBI
4	Balagué F, Nordin M, Shelkhzadeh A, et al: Recovery of severe sciatica. Spine (Phila Pa 1976). 24:2516–2524. 1999.
5	Igarashi T, Kikuchi S, Shubayev V, et al: 2000 Volvo Award winner in basic science studies: Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine (Phila Pa 1976). 25:2975–2980. 2000.
6	Yoon ST and Patel NM: Molecular therapy of the intervertebral disc. Eur Spine J. 15(Suppl 3): S379–S388. 2006. View Article : Google Scholar : PubMed/NCBI
7	Kuh SU, Zhu Y, Li J, et al: A comparison of three cell types as potential candidates for intervertebral disc therapy: annulus fibrosus cells, chondrocytes, and bone marrow derived cells. Joint Bone Spine. 76:70–74. 2009. View Article : Google Scholar : PubMed/NCBI
8	Zhao CQ, Wang LM, Jiang LS and Dai LY: The cell biology of intervertebral disc aging and degeneration. Ageing Res Rev. 6:247–261. 2007. View Article : Google Scholar : PubMed/NCBI
9	Diefenderfer DL and Brighton CT: Microvascular pericytes express aggrecan message which is regulated by BMP-2. Biochem Biophys Res Commun. 269:172–178. 2000. View Article : Google Scholar : PubMed/NCBI
10	Tim Yoon S, Su Kim K, Li J, et al: The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine (Phila Pa 1976). 28:1773–1780. 2003.PubMed/NCBI
11	Fassett DR, Kurd MF and Vaccaro AR: Biologic solutions for degenerative disc disease. J Spinal Disord Tech. 22:297–308. 2009. View Article : Google Scholar : PubMed/NCBI
12	Bogduk N: What’s in a name? The labelling of back pain. Med J Aust. 173:400–401. 2000.
13	Wattiez R, Hermans C, Bernard A, Lesur O and Falmagne P: Human bronchoalveolar lavage fluid: two-dimensional gel electrophoresis, amino acid microsequencing and identification of major proteins. Electrophoresis. 20:1634–1645. 1999. View Article : Google Scholar : PubMed/NCBI
14	Saintigny G, Schmidt R, Shroot B, Juhlin L, Reichert U and Michel S: Differential expression of calgranulin A and B in various epithelia cell lines and reconstructed epidermis. J Invest Dermatol. 99:639–644. 1992. View Article : Google Scholar : PubMed/NCBI
15	Ruebelt MC, Lipp M, Reynolds TL, et al: Application of two-dimensional gel electrophoresis to interrogate alterations in the proteome of genetically modified crops. 3. Assessing unintended effects. J Agric Food Chem. 54:2169–2177. 2006. View Article : Google Scholar
16	Lee EG, Kim JH, Shin YS, et al: Application of proteomics for comparison of proteome of Neospora caninum and Toxoplasma gondii tachyzoites. J Chromatogr B Analyt Technol Biomed Life Sci. 815:305–314. 2005. View Article : Google Scholar : PubMed/NCBI
17	Tan Y, Lv ZP and Zhang XF: Proteome and its application in liver disease research. Zhonghua Gan Zang Bing Za Zhi. 12:700–702. 2004.(In Chinese).
18	Nomura F, Tomonaga T, Sogawa K, et al: Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization-mass spectrometry. Proteomics. 4:1187–1194. 2004. View Article : Google Scholar : PubMed/NCBI
19	Tilleman K, Van Beneden K, Dhondt A, et al: Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry. Proteomics. 5:2247–2257. 2005. View Article : Google Scholar : PubMed/NCBI
20	Tan X, Cai D, Wu Y, et al: Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head. Transl Res. 148:114–119. 2006. View Article : Google Scholar : PubMed/NCBI
21	Liu XD, Zeng BF, Xu JG, et al: Proteomic analysis of the cerebrospinal fluid of patients with lumbar disc herniation. Proteomics. 6:1019–1028. 2006. View Article : Google Scholar : PubMed/NCBI
22	Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI
23	Görg A, Obermaier C, Boguth G, et al: The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 21:1037–1053. 2000.
24	Wilkins MR, Williams KL, Appel RD and Hochstrasser DF: Proteome Research: New Frontiers in Functional Genomics. Springer; Heidelberg: pp. 188–219. 1997
25	Duchateau PN, Pullinger CR, Orellana RE, et al: Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J Biol Chem. 272:25576–25582. 1997. View Article : Google Scholar
26	Horrevoets AJ, Fontijn RD, van Zonneveld AJ, et al: Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood. 93:3418–3431. 1999.
27	Duchateau PN, Movsesyan I, Yamashita S, et al: Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J Lipid Res. 41:1231–1236. 2000.
28	Cuellar JM, Montesano PX and Carstens E: Role of TNF-alpha in sensitization of nociceptive dorsal horn neurons induced by application of nucleus pulposus to L5 dorsal root ganglion in rats. Pain. 110:578–587. 2004. View Article : Google Scholar : PubMed/NCBI
29	Murata Y, Nannmark U, Rydevik B, et al: The role of tumor necrosis factor-alpha in apoptosis of dorsal root ganglion cells induced by herniated nucleus pulposus in rats. Spine (Phila Pa 1976). 33:155–162. 2008. View Article : Google Scholar : PubMed/NCBI
30	Bachmeier BE, Nerlich AG, Weiler C, et al: Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann NY Acad Sci. 1096:44–54. 2007. View Article : Google Scholar
31	Brisby H, Olmarker K, Larsson K, et al: Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J. 11:62–66. 2002. View Article : Google Scholar : PubMed/NCBI
32	Pérez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, et al: Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science. 309:469–472. 2005.PubMed/NCBI
33	Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, et al: Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature. 422:83–87. 2003. View Article : Google Scholar : PubMed/NCBI
34	Wan G, Zhaoriqetu S, Liu Z, et al: Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J Biol Chem. 283:21540–21549. 2008. View Article : Google Scholar : PubMed/NCBI
35	Clemmensen I, Petersen LC and Kluft C: Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem. 156:327–333. 1986. View Article : Google Scholar : PubMed/NCBI
36	Caterer NR, Graversen JH, Jacobsen C, et al: Specificity determinants in the interaction of apolipoprotein(a) kringles with tetranectin and LDL. Biol Chem. 383:1743–1750. 2002. View Article : Google Scholar : PubMed/NCBI
37	Kluft C, Jie AF, Los P, et al: Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin. Biochem Biophys Res Commun. 161:427–433. 1989. View Article : Google Scholar : PubMed/NCBI
38	Mogues T, Etzerodt M, Hall C, et al: Tetranectin binds to the kringle 1–4 form of angiostatin and modifies its functional activity. J Biomed Biotechnol. 2004.73–78. 2004.
39	Westergaard UB, Andersen MH, Heegaard CW, et al: Tetranectin binds hepatocyte growth factor and tissue-type plasminogen activator. Eur J Biochem. 270:1850–1854. 2003. View Article : Google Scholar : PubMed/NCBI
40	Borregaard N, Christensen L, Bejerrum OW, et al: Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest. 85:408–416. 1990. View Article : Google Scholar
41	Clemmensen I, Lund LR, Christensen L and Andreasen PA: A tetranectin-related protein is produced and deposited in extracellular matrix by human embryonal fibroblasts. Eur J Biochem. 195:735–741. 1991. View Article : Google Scholar : PubMed/NCBI
42	Nielsen H, Clemmensen I and Kharazmi A: Tetranectin: a novel secretory protein from human monocytes. Scand J Immunol. 37:39–42. 1993. View Article : Google Scholar : PubMed/NCBI
43	Wewer UM, Iba K, Durkin ME, et al: Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro. Dev Biol. 200:247–259. 1998. View Article : Google Scholar : PubMed/NCBI
44	Wewer UM, Ibaraki K, Schjørring P, et al: A potential role for tetranectin in mineralization during osteogenesis. J Cell Biol. 127:1767–1775. 1994. View Article : Google Scholar : PubMed/NCBI
45	Christensen L: The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix. APMIS Suppl. 26:1–39. 1992.PubMed/NCBI
46	Kamper EF, Kopeikina LT, Trontzas P, et al: Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis. Clin Rheumatol. 17:318–324. 1998. View Article : Google Scholar : PubMed/NCBI
47	Kluft C, Los P, Clemmensen I, et al: Quantitation of plasma levels of tetranectin - effects of oral contraceptives, pregnancy, treatment with L-asparaginase and liver cirrhosis. Thromb Haemost. 62:792–796. 1989.PubMed/NCBI
48	Xu N and Dahlbäck B: A novel human apolipoprotein (apoM). J Biol Chem. 274:31286–31290. 1999. View Article : Google Scholar : PubMed/NCBI
49	Xu N, Hurtig M, Zhang XY, Ye Q and Nilsson-Ehle P: Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells. Biochim Biophys Acta. 1683:33–37. 2004. View Article : Google Scholar : PubMed/NCBI
50	Luo G, Zhang X, Nilsson-Ehle P and Xu N: Apolipoprotein M. Lipids Health Dis. 3:212004. View Article : Google Scholar